A few months ago, a paper was published titled, "Developing Consensus for a More Provider-Friendly Next Generation Sequencing Molecular Biomarker Report: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists' published in The Journal of Molecular Diagnostics."
I'm wondering if any of your organizations have reviewed and discussed this paper internally. Are you planning on making any changes to your NGS reports?
You can read about this work here: https://www.amp.org/clinical-practice/improving-molecular-biomarker-reporting/